Loading...
•
Dec 31, 2024
Amedisys Q4 2024 Earnings Report
Amedisys reported its financial results for the fourth quarter and year ended December 31, 2024, with a decrease in net income attributable to Amedisys, Inc. and an increase in net service revenue.
Key Takeaways
Amedisys reported a net service revenue increase to $598.1 million in Q4 2024, up from $570.8 million in Q4 2023. However, the company experienced a net loss attributable to Amedisys, Inc. of $20.4 million, or $0.62 per diluted share, primarily due to merger-related expenses and a non-cash goodwill and other intangibles impairment charge.
Net service revenue increased by $27.3 million to $598.1 million in Q4 2024.
The company reported a net loss attributable to Amedisys, Inc. of $20.4 million in Q4 2024, compared to a net income of $19.3 million in Q4 2023.
Diluted EPS was -$0.62 in Q4 2024, a decrease from $0.59 in Q4 2023.
Adjusted EBITDA for Q4 2024 was $54.6 million, a slight decrease from $56.7 million in Q4 2023.
Forward Guidance
Amedisys will not conduct a quarterly earnings call to discuss the fourth quarter and year-end results due to the pending merger with UnitedHealth Group Incorporated.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...